Merck Manual

Please confirm that you are a health care professional

honeypot link

Milk Thistle

(Silymarin)

By

Laura Shane-McWhorter

, PharmD, University of Utah College of Pharmacy

Last full review/revision Jul 2020| Content last modified Jul 2020
Click here for Patient Education

Milk thistle (Silybum marianum) is a purple-flowered plant. Its sap and seeds contain the active ingredient silymarin, a potent antioxidant and a term often used interchangeably with milk thistle. Silymarin can be further divided into 3 primary flavonoids: silybin, silydianin, and silychristin. Extracts of milk thistle should be standardized to 80 percent silymarin.

Claims

Evidence

A 2007 Cochrane review of 13 randomized clinical trials assessed milk thistle in 915 patients with alcoholic and/or hepatitis B or C virus liver diseases (4) Milk thistle references Milk thistle (Silybum marianum) is a purple-flowered plant. Its sap and seeds contain the active ingredient silymarin, a potent antioxidant and a term often used interchangeably with milk thistle... read more . Data from this analysis determined that intervention had no significant effect on all-cause mortality, complications of liver disease, or liver histology. When all trials were included in the analysis, liver-related mortality was significantly reduced; however, in an analysis limited to high-quality studies, this reduction was not significant. Milk thistle was not associated with a significant increase in adverse effects. The design of these clinical trials did come into question, and the authors questioned the benefits of milk thistle and suggested the need for more well-designed placebo-controlled studies.

A 2018 systematic review and meta-analysis of 7 studies (370 subjects) found that milk thistle significantly decreased fasting glucose by 37.9 mg/dL (2.1 mmol/L) and hemoglobin A1C by 1.4% (2) Milk thistle references Milk thistle (Silybum marianum) is a purple-flowered plant. Its sap and seeds contain the active ingredient silymarin, a potent antioxidant and a term often used interchangeably with milk thistle... read more .

Adverse effects

No serious adverse effects have been reported. Women who have hormone-sensitive conditions (eg, breast, uterine, and ovarian cancer; endometriosis; uterine fibroids) should avoid the above-ground parts of milk thistle.

Drug interactions

Milk thistle references

  • Abenavoli L, Izzo AA, Milic N, et al: Milk thistle (Silybum marianum): a concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytother Res 32(11):2202-2213, 2018. doi: 10.1002/ptr.6171.

  • Hadi A, Pourmasoumi M, Mohammadi H, et al: The effects of silymarin supplementation on metabolic status and oxidative stress in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of clinical trials. Complement Ther Med 41:311-319, 2018. doi: 10.1016/j.ctim.2018.08.010.

  • Ward J, Kapadia K, Brush E, et al: Amatoxin poisoning: case reports and review of current therapies. J Emerg Med 44(1):116-121, 2013. doi: 10.1016/j.jemermed.2012.02.020.

  • Rambaldi A, Jacobs BP, Gluud C: Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database Syst Rev (4)CD003620, 2007. doi: 10.1002/14651858.CD003620.pub3.

  • Yang Z, Zhuang L, Lu Y, et al: Effects and tolerance of silymarin (milk thistle) in chronic hepatitis C virus infection patients: a meta-analysis of randomized controlled trials. Biomed Res Int 941085, 2014. doi: 10.1155/2014/941085.

  • Valenzuela A, Aspillaga M, Vial S, et al: Selectivity of silymarin on the increase of the glutathione content in different tissues of the rat. Planta Med 55(5):420-422, 1989. doi: 10.1055/s-2006-962056.

  • Wu JW, Lin LC, Tsai TH: Drug-drug interactions of silymarin on the perspective of pharmacokinetics. J Ethnopharmacol 121(2):185-193, 2009. doi: 10.1016/j.jep.2008.10.036.

  • Jalloh MA, Gregory PJ, Hein D, et al: Dietary supplement interactions with antiretrovirals: a systematic review. Int J STD AIDS 28(1):4-15, 2017. doi: 10.1177/0956462416671087.

More Information

The following is an English-language resource that may be useful. Please note that THE MANUAL is not responsible for the content of this resource.

Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Professionals also read
Test your knowledge
The Dying Patient
If a patient is potentially dying, the patient should be as involved as possible with health-care decision making. However, if a patient lacks the ability to make health-care decisions and has no authorized surrogate, it is most appropriate to consult the patient’s spouse or domestic partner first. If the patient does not have a spouse or domestic partner, which of the following individuals is most appropriate to consult next? 
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID

Also of Interest

Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
TOP